Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals Revenue

In the year 2023, Regeneron Pharmaceuticals had annual revenue of $13.12B with 7.76% growth. Revenue in the quarter ending December 31, 2023 was $3.43B with 0.58% year-over-year growth.

• Revenue (ttm): $13.12B
• Revenue Growth: +7.76%
• P/S Ratio: 7.36
• Revenue / Employee: $975,257
• Employees: 13,450
• Market Cap: 96.52B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	13.12B	944.30M	7.76%
Dec 31, 2022	12.17B	-3.90B	-24.26%
Dec 31, 2021	16.07B	7.57B	89.14%
Dec 31, 2020	8.50B	1.94B	29.58%
Dec 31, 2019	6.56B	1.41B	27.44%
Dec 31, 2018	5.15B	-726.60M	-12.37%
Dec 31, 2017	5.87B	1.01B	20.82%
Dec 31, 2016	4.86B	756.67M	18.44%
Dec 31, 2015	4.10B	1.28B	45.55%
Dec 31, 2014	2.82B	714.81M	33.96%
Dec 31, 2013	2.10B	726.27M	52.69%
Dec 31, 2012	1.38B	932.65M	209.20%
Dec 31, 2011	445.82M	-13.25M	-2.89%
Dec 31, 2010	459.07M	79.81M	21.04%
Dec 31, 2009	379.27M	140.81M	59.05%
Dec 31, 2008	238.46M	113.43M	90.73%
Dec 31, 2007	125.02M	61.58M	97.05%
Dec 31, 2006	63.45M	-2.75M	-4.15%
Dec 31, 2005	66.19M	-107.82M	-61.96%
Dec 31, 2004	174.02M	116.52M	202.65%
Dec 31, 2003	57.50M	35.51M	161.49%
Dec 31, 2002	21.99M	15.00K	0.07%
Dec 31, 2001	21.97M	-37.30M	-62.93%
Dec 31, 2000	59.28M	24.78M	71.82%
Dec 31, 1999	34.50M	-3.83M	-9.99%
Dec 31, 1998	38.33M	5.23M	15.79%
Dec 31, 1997	33.10M	8.99M	37.26%
Dec 31, 1996	24.11M	-3.27M	-11.94%
Dec 31, 1995	27.38M	4.19M	18.08%
Dec 31, 1994	23.19M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.